Risultati della ricerca - Azad, Arun

Metastatic non-small cell lung cancer presenting with an orbital metastasis: a case report di Azad, Arun

Testo Testo Testo

Severe cutaneous toxicity following treatment with radiotherapy and cetuximab: a case report di Azad, Arun

Testo Testo Testo

Dexamethasone-induced flares of Trichophyton rubrum masquerading as docetaxel cutaneous toxicity: a case report di Azad, Arun, Kaufman, Melissa, Jayarajan, Jyotsna

Testo Testo Testo

Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET? di Alipour, Ramin, Azad, Arun, Hofman, Michael S.

Testo Testo Testo

Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab di Gan, Hui K., Azad, Arun, Cher, Lawrence, Mitchell, Paul L.R.

Testo Testo Testo

Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer di Zielinski, Robert R., Azad, Arun A., Chi, Kim N., Tyldesely, Scott

Testo Testo Testo

Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review di Ong, Sean, O’Brien, Jonathan, Medhurst, Elizabeth, Lawrentschuk, Nathan, Murphy, Declan, Azad, Arun

Testo Testo Testo

Local and systemic modulation of the PD-L1 pathway is a novel mechanism of Enzalutamide resistance in castration-resistant prostate cancer di Bishop, Jennifer, Sio, Alexander, Angeles, Arkhjamil, Roberts, Morgan, Azad, Arun, Chi, Kim, Zoubeidi, Amina

Testo Testo

Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19 di Sean Ong, Xuan Rui, Condon, Benjamin, Bagguley, Dominic, Lawrentschuk, Nathan, Azad, Arun, Murphy, Declan

Testo Testo Testo

SAT-330 Preclinical Screen of Patient CRPC Tumors Shows Sensitivity to Bromodomain Inhibitors Includes AR-null and Neuroendocrine Disease di Risbridger, Gail, Ashikari, Daisaku, Lawrence, Mitchell, Obinata, Daisuke, Wang, Hong, Sandhu, Shahneen, Azad, Arun, Taylor, Renea

Testo Testo

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer di Bishop, Jennifer L., Sio, Alexander, Angeles, Arkhjamil, Roberts, Morgan E., Azad, Arun A., Chi, Kim N., Zoubeidi, Amina

Testo Testo

Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer di Perera, Mahasha P.J., Thomas, Patrick B., Risbridger, Gail P., Taylor, Renea, Azad, Arun, Hofman, Michael S., Williams, Elizabeth D., Vela, Ian

Testo Testo Testo

Preclinical Evidence of the Efficacy of Lewis Y Car T Cells in Patient-Derived Models of Prostate Cancer di Risbridger, Gail Petuna, Porter, Laura Helen, Zhu, Joe, Byrne, David, Lister, Natalie, Azad, Arun, Hofman, Michael, Vela, Ian, Taylor, Renea A, Neeson, Paul, Darcy, Phil, Trapani, Joseph

Testo Testo

A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate di Khalaf, Daniel Joseph, Avilés, Claudia M., Azad, Arun A., Sunderland, Katherine, Todenhöfer, Tilman, Eigl, Berhard J., Finch, Daygen, Le, Lyly, Atwell, Andrew, Keith, Bruce, Kollmannsberger, Christian, Chi, Kim. N.

Testo Testo Testo

Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late di IJzerman, Maarten J., de Boer, Jasper, Azad, Arun, Degeling, Koen, Geoghegan, Joel, Hewitt, Chelsee, Hollande, Frédéric, Lee, Belinda, To, Yat Ho, Tothill, Richard W., Wright, Gavin, Tie, Jeanne, Dawson, Sarah-Jane

Testo Testo Testo

(177)Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II... di Pathmanandavel, Sarennya, Crumbaker, Megan, Yam, Andrew O., Nguyen, Andrew, Rofe, Christopher, Hovey, Elizabeth, Gedye, Craig, Kwan, Edmond M., Hauser, Christine, Azad, Arun A., Eu, Peter, Martin, Andrew J., Joshua, Anthony M., Emmett, Louise

Testo Testo Testo

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer di Armstrong, Andrew J., Szmulewitz, Russell Z., Petrylak, Daniel P., Holzbeierlein, Jeffrey, Villers, Arnauld, Azad, Arun, Alcaraz, Antonio, Alekseev, Boris, Iguchi, Taro, Shore, Neal D., Rosbrook, Brad, Sugg, Jennifer, Baron, Benoit, Chen, Lucy, Stenzl, Arnulf

Testo Testo Testo

Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer di Kohli, Manish, Tan, Winston, Zheng, Tiantian, Wang, Amy, Montesinos, Carlos, Wong, Calven, Du, Pan, Jia, Shidong, Yadav, Siddhartha, Horvath, Lisa G., Mahon, Kate L., Kwan, Edmond M., Fettke, Heidi, Yu, Jianjun, Azad, Arun A.

Testo Testo Testo

Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer di Anton, Angelyn, Pillai, Sruti, Semira, Marie Christine, Wong, Shirley, Shapiro, Julia, Weickhardt, Andrew, Azad, Arun, Kwan, Edmond M., Spain, Lavinia, Gunjur, Ashray, Torres, Javier, Parente, Phillip, Parnis, Francis, Goh, Jeffrey, Baenziger, Olivia, Gibbs, Peter, Tran, Ben

Testo Testo Testo

A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol di Pryor, David, Bressel, Mathias, Lawrentschuk, Nathan, Tran, Ben, Mooi, Jennifer, Lewin, Jeremy, Azad, Arun, Colyer, Duncan, Neha, Nitika, Shaw, Mark, Chander, Sarat, Neeson, Paul, Moon, Daniel, Cuff, Katharine, Wood, Simon, Murphy, Declan G., Sandhu, Shahneen, Loi, Sherene, Siva, Shankar

Testo Testo Testo